company background image
ALEMS logo

European Medical Solutions ENXTBR:ALEMS Stock Report

Last Price

€0.018

Market Cap

€26.8m

7D

-6.3%

1Y

-16.3%

Updated

24 Dec, 2024

Data

Company Financials

European Medical Solutions

ENXTBR:ALEMS Stock Report

Market Cap: €26.8m

ALEMS Stock Overview

Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. More details

ALEMS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

European Medical Solutions Competitors

Price History & Performance

Summary of share price highs, lows and changes for European Medical Solutions
Historical stock prices
Current Share Price€0.018
52 Week High€0.037
52 Week Low€0.0024
Beta0.57
1 Month Change-5.26%
3 Month Change-7.22%
1 Year Change-16.28%
3 Year Change-91.71%
5 Year Change-94.23%
Change since IPO-99.73%

Recent News & Updates

Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?

Dec 13
Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?

Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

Jun 15
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

Dec 21
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

Recent updates

Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?

Dec 13
Does European Medical Solutions (EBR:ALEMS) Have A Healthy Balance Sheet?

Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

Jun 15
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?

DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

Dec 21
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward

DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity

Jun 15
DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity

Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly

Dec 29
Here's Why DMS Imaging (EBR:DMSIM) Can Manage Its Debt Responsibly

Shareholder Returns

ALEMSBE BiotechsBE Market
7D-6.3%0.03%-0.4%
1Y-16.3%11.8%0.6%

Return vs Industry: ALEMS underperformed the Belgian Biotechs industry which returned 11% over the past year.

Return vs Market: ALEMS underperformed the Belgian Market which returned 0.2% over the past year.

Price Volatility

Is ALEMS's price volatile compared to industry and market?
ALEMS volatility
ALEMS Average Weekly Movement5.6%
Biotechs Industry Average Movement7.8%
Market Average Movement3.6%
10% most volatile stocks in BE Market6.6%
10% least volatile stocks in BE Market2.1%

Stable Share Price: ALEMS's share price has been volatile over the past 3 months compared to the Belgian market.

Volatility Over Time: ALEMS's weekly volatility has decreased from 11% to 6% over the past year, but is still higher than 75% of Belgian stocks.

About the Company

FoundedEmployeesCEOWebsite
1979125Samuel Sancerniwww.dms-imaging.com

European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024.

European Medical Solutions Fundamentals Summary

How do European Medical Solutions's earnings and revenue compare to its market cap?
ALEMS fundamental statistics
Market cap€26.81m
Earnings (TTM)-€1.07m
Revenue (TTM)€43.93m

0.6x

P/S Ratio

-25.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALEMS income statement (TTM)
Revenue€43.93m
Cost of Revenue€28.45m
Gross Profit€15.48m
Other Expenses€16.55m
Earnings-€1.07m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.00072
Gross Margin35.23%
Net Profit Margin-2.44%
Debt/Equity Ratio133.4%

How did ALEMS perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 07:36
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

European Medical Solutions is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hugo SolvetBryan Garnier & Co
Andrew SmithEdison Investment Research
Stephanie LefebvreGilbert Dupont